Cargando…

Role of maspin in cancer

Maspin (mammary serine protease inhibitor), is a member of the serine protease inhibitor/non-inhibitor superfamily. Its expression is down-regulated in breast, prostate, gastric and melanoma cancers but over-expressed in pancreatic, gallbladder, colorectal, and thyroid cancers suggesting that maspin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berardi, Rossana, Morgese, Francesca, Onofri, Azzurra, Mazzanti, Paola, Pistelli, Mirco, Ballatore, Zelmira, Savini, Agnese, De Lisa, Mariagrazia, Caramanti, Miriam, Rinaldi, Silvia, Pagliaretta, Silvia, Santoni, Matteo, Pierantoni, Chiara, Cascinu, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602294/ https://www.ncbi.nlm.nih.gov/pubmed/23497644 http://dx.doi.org/10.1186/2001-1326-2-8

Ejemplares similares

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
por: Berardi, Rossana, et al.
Publicado: (2013)

Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials
por: Berardi, Rossana, et al.
Publicado: (2016)

Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex
por: Berardi, Rossana, et al.
Publicado: (2016)

Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy
por: Berardi, Rossana, et al.
Publicado: (2015)

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions
por: Berardi, Rossana, et al.
Publicado: (2020)

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer
por: Berardi, Rossana, et al.
Publicado: (2010)

Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients
por: Morgese, Francesca, et al.
Publicado: (2017)

Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients
por: Pistelli, Mirco, et al.
Publicado: (2015)

Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review
por: De Lisa, Mariagrazia, et al.
Publicado: (2020)

Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
por: Pistelli, Mirco, et al.
Publicado: (2014)

Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Expectations and psychological issues before genetic counseling: analysis of distress determinant factors
por: Ballatore, Zelmira, et al.
Publicado: (2020)

Correction to: Expectations and psychological issues before genetic counseling: analysis of distress determinant factors
por: Ballatore, Zelmira, et al.
Publicado: (2020)

Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type
por: Maccaroni, Elena, et al.
Publicado: (2021)

Gender differences and outcome of melanoma patients
por: Morgese, Francesca, et al.
Publicado: (2015)

Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study
por: Berardi, Rossana, et al.
Publicado: (2020)

Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms
por: Berardi, Rossana, et al.
Publicado: (2018)

Systemic treatment for lung carcinoids: from bench to bedside
por: Torniai, Mariangela, et al.
Publicado: (2019)

Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report
por: Ballatore, Z., et al.
Publicado: (2016)

The Impact of Lifestyle Interventions in High-Risk Early Breast Cancer Patients: A Modeling Approach from a Single Institution Experience
por: Pistelli, Mirco, et al.
Publicado: (2021)

Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience
por: Pistelli, Mirco, et al.
Publicado: (2021)

Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2020)

Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy
por: Giampieri, Riccardo, et al.
Publicado: (2019)

Gender Differences and Outcomes in Melanoma Patients
por: Morgese, Francesca, et al.
Publicado: (2020)

A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2023)

Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management
por: Berardi, Rossana, et al.
Publicado: (2020)

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management
por: Mentrasti, Giulia, et al.
Publicado: (2020)

Managing hyponatremia in lung cancer: latest evidence and clinical implications
por: Fiordoliva, Ilaria, et al.
Publicado: (2017)

Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology
por: Agostinelli, Veronica, et al.
Publicado: (2023)

High CTLA-4 expression correlates with poor prognosis in thymoma patients
por: Santoni, Giorgio, et al.
Publicado: (2018)

Management of lung cancer patients during COVID-19 pandemic: dos, don’ts and don’t knows
por: Torniai, Mariangela, et al.
Publicado: (2022)

Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
por: Conti, Alessandro, et al.
Publicado: (2013)

Maspin expression in gastrointestinal stromal tumors
por: Adim, Saduman Balaban, et al.
Publicado: (2010)

[(11)C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas
por: Santoni, Matteo, et al.
Publicado: (2014)

Clinicopathological Significance of Maspin Expression in Breast Cancer
por: Lee, Mi-Ja, et al.
Publicado: (2006)

Maspin is not required for embryonic development or tumour suppression
por: Teoh, Sonia S. Y., et al.
Publicado: (2014)

Prognostic Significance of Maspin in Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

Unexpected maspin immunoreactivity in Merkel cell carcinoma
por: Turdean, Sabin Gligore, et al.
Publicado: (2015)

The associated expression of Maspin and Bax proteins as a potential prognostic factor in intrahepatic cholangiocarcinoma
por: Romani, Antonello A, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_aap4kiqvlgt4drabjanb72hrrh